An Effective and Safe Novel Treatment of Opioid Use Disorder

Background: The opioid epidemic is a global tragedy even with current treatments, and a novel, safe, and effective treatment would be welcomed. We report here our findings from our second randomized controlled trial to evaluate unilateral transcranial photobiomodulation as a treatment for opioid use disorder. Methods: We enrolled 39 participants with active opioid cravings at 2 sites, 19 received the active treatment which consisted of a 4-min twice weekly (every 3 or 4 days) application of a light-emitting diode at 810 nm with an irradiance of 250 mW/cm 2 and a fluence of 60 J/cm 2 to the forehead over either the left or right dorsolateral prefrontal cortex with a fluence to the brain of 2.1 J/cm 2 . Twenty participants received a sham treatment with the same device with foil over the bulb. The side of the treatment was based on Dual-Brain Psychology, which posits that one hemisphere is more affected by past maltreatments and is more prone to anxiety and drug cravings that the other hemisphere. We treated the hemisphere with the more positive hemispheric emotional valence (HEV) by 2 tests for HEV. Results: Our primary outcome was changes in pre-treatment opioid craving scale (OCS) minus baseline, and we found using a mixed model that the active group had a highly significant treatment * time benefit over the sham group, p p = 0.0001, with an effect size of 0.45. We observed no adverse effects. Conclusion: Active unilateral transcranial photobiomodulation to the brain hemisphere with the better HEV was better than sham in the reduction of opioid cravings and opioid use to a very significant degree in a RCT of 39 participants at 2 independent sites. In the active group those on buprenorphine and those not on it both had improvements in cravings over the study. No adverse responses were reported in either group. ClinicalTrials.gov Identifier: NCT04340622

Addiction · Anesthesia · Craving · Opioid · Opioid use disorder · Psychiatry · Randomized controlled trial · Dental Anxiety and Anesthesia Techniques · Laser Applications in Dentistry and Medicine · Medicine · Migraine and Headache Studies · Psychology · Internal Medicine

• Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

  Richard P Mattick, Courtney Breen et al.•Cochrane Database of Systematic…•2014

  Añadir item

• The Timeline Followback reports of psychoactive substance use by drug-abusing patients

  William Fals‐stewart, William Fals-Stewart et al.•Journal of Consulting and…•2000

  Añadir item

• Timeline Follow-Back

  Linda C Sobell, Mark B Sobell•Measuring Alcohol Consumption•1992

  Añadir item

• A Rating Scale for Depression

  M Hamilton•Journal of Neurology Neurosurgery…•1960

  Añadir item

• A Novel Treatment of Opioid Cravings With an Effect Size of .73 for Unilateral Transcranial Photobiomodulation Over Sham

  Open Access•Fredric Schiffer, William M Reichmann et al.•Frontiers in Psychiatry•2020

  Añadir item

• The Assessment of Anxiety States by Rating

  Open Access•MAX HAMILTON•British Journal of Medical…•1959

  Añadir item

• Toward a consensual structure of mood

  David Watson, David C Watson et al.•Psychological Bulletin•1985

  Añadir item